Equity Capital Markets

Company · CIK 1825367

RayzeBio, Inc.

CIK1825367 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2023-11-13

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-274193
IPOFinal prospectus
 2023-08-242023-09-184

Filings

5
FiledFilingRegistrationAccession
2023-09-18424B4Final prospectus 333-2741930001193125-23-237010
2023-09-14EFFECTDeclared effective 333-2741939999999995-23-002665
2023-09-11S-1/AAmendment 333-2741930001193125-23-231908
2023-08-24S-1Registration filed 333-2741930001193125-23-220093
2022-02-11DRSDraft made public 377-060080000950123-22-002178

All filings of this company · CSV